IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,441,549 | +289.6% | 75,991 | +218.5% | 0.01% | +400.0% |
| Q1 2023 | $370,007 | +16.4% | 23,856 | -58.2% | 0.00% | 0.0% |
| Q3 2022 | $318,000 | +29.3% | 57,027 | -9.5% | 0.00% | – |
| Q2 2022 | $246,000 | -21.9% | 63,047 | +10.4% | 0.00% | – |
| Q1 2022 | $315,000 | -56.1% | 57,110 | -32.2% | 0.00% | -100.0% |
| Q4 2021 | $718,000 | +3.5% | 84,294 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $694,000 | +109.7% | 79,812 | +155.3% | 0.00% | – |
| Q2 2021 | $331,000 | +114.9% | 31,268 | +224.8% | 0.00% | – |
| Q1 2021 | $154,000 | – | 9,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,500,000 | $26,625 | 8.85% |
| Deep Track Capital, LP | 9,710,000 | $172,352,500 | 7.24% |
| Logos Global Management LP | 3,150,000 | $55,912,500 | 6.55% |
| Ikarian Capital, LLC | 966,700 | $17,158,925 | 4.14% |
| COMMODORE CAPITAL LP | 1,150,505 | $20,421 | 3.08% |
| TCG Crossover Management, LLC | 854,853 | $15,173,641 | 2.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 519,614 | $9,223,149 | 2.64% |
| COWEN AND COMPANY, LLC | 1,250,000 | $22,187,500 | 2.32% |
| BVF INC/IL | 2,561,000 | $45,457,750 | 1.92% |
| Eventide Asset Management | 3,693,720 | $65,563,530 | 1.29% |